PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.77%
Revenue growth above 1.5x 3391.T's 2.06%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
2.33%
Gross profit growth above 1.5x 3391.T's 1.34%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
7.47%
EBIT growth similar to 3391.T's 8.12%. Walter Schloss might infer both firms share similar operational efficiencies.
11.60%
Operating income growth above 1.5x 3391.T's 6.25%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
7.06%
Net income growth at 50-75% of 3391.T's 12.20%. Martin Whitman would question fundamental disadvantages in expenses or demand.
7.10%
EPS growth at 50-75% of 3391.T's 12.26%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
7.10%
Diluted EPS growth at 50-75% of 3391.T's 11.85%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.00%
Share change of 0.00% while 3391.T is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.00%
Diluted share reduction more than 1.5x 3391.T's 0.32%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-113.60%
Negative OCF growth while 3391.T is at 112.52%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-470.38%
Negative FCF growth while 3391.T is at 108.92%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
30.78%
10Y revenue/share CAGR above 1.5x 3391.T's 17.91%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
30.78%
5Y revenue/share CAGR above 1.5x 3391.T's 17.91%. David Dodd would look for consistent product or market expansions fueling outperformance.
30.78%
3Y revenue/share CAGR above 1.5x 3391.T's 17.91%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
73.51%
Positive long-term OCF/share growth while 3391.T is negative. John Neff would see a structural advantage in sustained cash generation.
73.51%
Positive OCF/share growth while 3391.T is negative. John Neff might see a comparative advantage in operational cash viability.
73.51%
Positive 3Y OCF/share CAGR while 3391.T is negative. John Neff might see a big short-term edge in operational efficiency.
96.43%
Net income/share CAGR above 1.5x 3391.T's 50.25% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
96.43%
5Y net income/share CAGR above 1.5x 3391.T's 50.25%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
96.43%
3Y net income/share CAGR above 1.5x 3391.T's 50.25%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
48.59%
10Y equity/share CAGR above 1.5x 3391.T's 17.63%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
48.59%
5Y equity/share CAGR above 1.5x 3391.T's 17.63%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
48.59%
3Y equity/share CAGR above 1.5x 3391.T's 17.63%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.84%
Inventory is declining while 3391.T stands at 2.83%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.83%
Negative asset growth while 3391.T invests at 0.91%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.96%
BV/share growth above 1.5x 3391.T's 2.36%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-10.36%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.